NCT07784959
- Conditions
- ALK Positive, ALK Positive Non-small Cell Lung Cancer, ALK+ Non-Small-Cell Lung Carcinoma, +1 more
- Locations
-
- NEXT Virginia Fairfax, Virginia, United States
Clinical trial condition
ALK Positive Non-small Cell Lung Cancer
Explore clinical trials studying ALK Positive Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
4 public trials
3 recruiting studies
ALK Positive Non-small Cell Lung Cancer trial results
NCT07617337
- Conditions
- ALK Positive Non-small Cell Lung Cancer
- Locations
-
- Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
- Kindai University Hospital Sakai, Osaka, Japan
- Shizuoka Cancer Center Nagaizumi-cho, Shizuoka, Japan
- National Cancer Center Hospital Chuo-ku, Tokyo, Japan
NCT06092086
- Conditions
- ALK Positive Non-small Cell Lung Cancer
- Locations
-
- Guangdong Provincial Perople's Hospital Guangzhou, Guangdong, China
Not yet recruiting
Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLC
NCT07750704
- Conditions
- ALK Positive Non-small Cell Lung Cancer
- Locations
-
- Guangdong Provincial Perople's Hospital Guangzhou, Guangdong, China